Search Tag: Venous Thromboembolism

ICU Management

2018 13 Jun

There is concern about excessive bleeding when low-molecular-weight heparins (LMWHs) are used for venous thromboembolism (VTE) prophylaxis in renal dysfunction. To evaluate whether LMWH VTE prophylaxis was safe and effective in critically ill patients with renal dysfunction, researchers conducted a subgroup analysis of PROTECT, a randomised trial...Read more

ICU Management

2016 02 Jun

The first European recommendations on postoperative venous thromboembolism (VTE)  are on their way, and are intended to be much more practical and clinical than the U.S. recommendations, said Prof. Charles-Marc Samama , Chair of the European Task Force on Prevention of  Venous Thromboembolism in Anaesthesia and Intensive Care and Chair of the ESA...Read more

ICU Management

2014 17 Nov

Key Messages 1. We need to Identify high risk patients early on during their hospital admission. 2. Recognise anticoagulant prophylaxis may not be suitable for all patients therefore consider other interventions to protect against VTE. 3. Focus on sustained education of healthcare professionals to increase   Venous thromboembolism...Read more

ICU Management

2014 01 Nov

According to a study published in JAMA, prevention of venous thromboembolism (VTE) with low-molecular-weight heparin (LMWH) dalteparin in critically ill patients was more effective and had similar or lower costs  compared to unfractionated heparin (UFH). The study is to be presented at the Critical Care Canada Forum. The PROTECT trial compared the...Read more